Cerebral cortex and the clinical expression of Huntington's disease: complexity and heterogeneity - Wikidata - thesis-toulmin - TriplyDB

Cerebral cortex and the clinical expression of Huntington's disease: complexity and heterogeneity

Cerebral cortex and the clinical expression of Huntington's disease: complexity and heterogeneity

http://www.wikidata.org/entity/Q37132239

about

Functional connectivity mapping of the human precuneus by resting state fMRI.Current status of PET imaging in Huntington's disease Role of cerebral cortex in the neuropathology of Huntington's disease Magnetic resonance imaging striatal volumes: a biomarker for clinical trials in Huntington's disease Detection of Motor Changes in Huntington's Disease Using Dynamic Causal Modeling.Evaluation of histone deacetylases as drug targets in Huntington's disease models. Study of HDACs in brain tissues from R6/2 and CAG140 knock-in HD mouse models and human patients and in a neuronal HD cell model A Network Diffusion Model of Disease Progression in Dementia Improvement of neuropathology and transcriptional deficits in CAG 140 knock-in mice supports a beneficial effect of dietary curcumin in Huntington's disease.Abnormal synchrony of resting state networks in premanifest and symptomatic Huntington disease: the IMAGE-HD study.Mouse models of Huntington's disease and methodological considerations for therapeutic trials.Alterations in cortical excitation and inhibition in genetic mouse models of Huntington's disease.Early changes in the hypothalamic region in prodromal Huntington disease revealed by MRI analysis.The effects of FreeSurfer version, workstation type, and Macintosh operating system version on anatomical volume and cortical thickness measurements Functional magnetic resonance imaging of working memory in Huntington's disease: cross-sectional data from the IMAGE-HD study.Neuroimaging in Huntington's disease.Robust MR-based approaches to quantifying white matter structure and structure/function alterations in Huntington's disease.In Vivo NMR Studies of the Brain with Hereditary or Acquired Metabolic Disorders.Tractography of the corpus callosum in Huntington's disease.Molecular Imaging of Huntington's Disease.Functional imaging in Huntington's disease.Magnetic resonance imaging of Huntington's disease: preparing for clinical trials.Prion-like transmission of protein aggregates in neurodegenerative diseases Survival prediction in Amyotrophic lateral sclerosis based on MRI measures and clinical characteristics Topological length of white matter connections predicts their rate of atrophy in premanifest Huntington's disease.Seeking brain biomarkers for preventive therapy in Huntington disease.Complexity and heterogeneity: what drives the ever-changing brain in Huntington's disease?Patterns of cortical thinning in the language variants of frontotemporal lobar degeneration Increased sensitivity to effects of normal aging and Alzheimer's disease on cortical thickness by adjustment for local variability in gray/white contrast: a multi-sample MRI study QEEG Measures in Huntington's Disease: A Pilot Study.Motor network degeneration in amyotrophic lateral sclerosis: a structural and functional connectivity study.Motor-Language Coupling in Huntington's Disease Families.Monomeric, oligomeric and polymeric proteins in huntington disease and other diseases of polyglutamine expansion Cognitive deficits in Huntington's disease on the Repeatable Battery for the Assessment of Neuropsychological Status.Neuropsychiatric Burden in Huntington's Disease.Rilmenidine attenuates toxicity of polyglutamine expansions in a mouse model of Huntington's disease."Frontal" behaviors before the diagnosis of Huntington's disease and their relationship to markers of disease progression: evidence of early lack of awareness.Microcirculation response to local cooling in patients with Huntington's disease.Combining tractography and cortical measures to test system-specific hypotheses in multiple sclerosis.Examination of Huntington's disease in a Chinese family Lack of efficacy of NMDA receptor-NR2B selective antagonists in the R6/2 model of Huntington disease.

P2860

Q24629707-FBEBFF60-4610-492D-A3CE-73CD44392213 Q26768644-76634278-E9ED-4C4C-B6E0-823EBC15716F Q26829211-F85630E9-134A-4EAD-8797-94B1D253A8A1 Q27004343-CD5D1164-55D5-44C5-A567-A5D90760AE71 Q27317122-127E1831-1FE0-430D-92C2-7B1F907086D2 Q28475537-0D07B8AA-6201-4549-914D-DEC999FB0A17 Q29543923-6337ED9B-C972-4E85-A437-D210ADDAE7AE Q30426968-128FCB6D-FEB3-4451-A566-E98905BC0E4A Q30441887-F2C9E2B8-ADB0-4AE7-9E52-99D7577F35DB Q30481208-AA5EC64C-B9A4-4010-A435-C0C90BF0EECA Q30490632-DA732F02-0CDF-44D6-ADD2-41A70C3055E7 Q30497024-DE2D6F18-6EC2-45C8-816B-47FF40692B15 Q30514477-A61F6D73-1C29-4994-9676-DEBA821C9AF8 Q30659199-8A22E0F7-3721-4386-B3BC-FE40BC4FDE50 Q30834004-A9D4381E-78E3-464D-9F9E-5444EC5281C0 Q30991345-DA07059C-367B-44F1-8A40-3DFE58E05624 Q31028468-6542B233-09D9-4877-BBA4-84481ADB5AF1 Q31137452-BB1BBBF3-6EE6-4AE9-929E-4A394974CFE8 Q31139686-81518F12-84DB-4F58-94EF-EC400E69DA9C Q33403110-1CD3D852-8F72-4B1A-AAB5-91E198E31F47 Q33437923-3F103E43-349D-4A6B-B7E5-C42D4C7E1619 Q33544162-15609EDF-13DA-4938-8F76-E96AD3C4763D Q33568729-198C6BC2-B2C2-4FDD-88A4-C517E74FD0C5 Q33579030-E14FB741-4069-4ED5-A775-FD0589FFFDFB Q33606063-22013CCA-9836-48ED-974F-D480F1269EC3 Q33619310-7EB5312E-29FC-4EB3-9DAA-5937F6DBE828 Q33682555-EF1FE94D-E03A-44E3-BCFB-74B6F8719178 Q33688690-A5757D2B-D7A0-48F5-AC94-90F59EE71856 Q33734662-E00B8CA9-2A67-41C2-A97E-F58E962EB434 Q33741815-643EB351-CD93-4D64-A6EC-289609BF2AB9 Q33743709-9371BE11-9E2D-49FB-BCD0-ADDEF6C82F09 Q33788913-AFA7A80B-C2D3-48C7-A1AD-FC700896A310 Q33790224-A1777C33-4684-4A39-B401-0857B1D2F4B9 Q33831793-112202B3-333E-4CCC-80EE-E8B76789BB0B Q33832866-AF2ADDB6-29B4-49AB-A2BD-4FC4A4DF1D71 Q33854599-D5526C0E-625D-45DC-ADFB-10843AE43B32 Q34052018-142DCAD8-9375-4D99-8DB0-C320E1E6D41C Q34078413-6869E32E-0FBB-4CE4-86F9-CFBF132FECBF Q34095823-D42C5E49-0CFA-44D4-B629-0B48C441594A Q34126315-B1CF9BEA-E23B-4016-ADF5-4C056BDA2E62

P2860

Cerebral cortex and the clinical expression of Huntington's disease: complexity and heterogeneity

http://www.wikidata.org/entity/Q37132239

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 12 March 2008

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Cerebral cortex and the clinic ...... : complexity and heterogeneity

@en

Cerebral cortex and the clinic ...... complexity and heterogeneity.

@nl

type

label

Cerebral cortex and the clinic ...... : complexity and heterogeneity

@en

Cerebral cortex and the clinic ...... complexity and heterogeneity.

@nl

prefLabel

Cerebral cortex and the clinic ...... : complexity and heterogeneity

@en

Cerebral cortex and the clinic ...... complexity and heterogeneity.

@nl

P1433

Q37132239-CE07133C-B866-410C-9979-5AFB4BBF30FF

P1476

Q37132239-C8474EF4-7E59-4135-8FC7-923DD0A2F2E4

P2093

Q37132239-2C6D20A8-031A-436F-892C-4C9A781AF03E

Q37132239-50741DCA-0325-405A-AA42-150BBFA9AA3A

Q37132239-B1CE79AD-2E9A-4B79-BF1A-B5404F583C77

Q37132239-C3CA7CE9-C5E1-406A-AA27-F938251DB4E9

Q37132239-DADADAEC-AE3D-4C5E-A2F7-2140AB9AAA8A

Q37132239-DF724156-D010-4B3D-A0DC-4177A74404C0

Q37132239-FDE926A8-466D-4C26-8A5D-AA85D7B604B5

P2860

Q37132239-0401190D-4D19-4B62-A7A4-C8D4E33326BC

Q37132239-0B6B3DAF-F4AB-4714-920A-6A24BB1B48CD

Q37132239-0C7AE711-BB7E-494C-B34A-D7AB2669430A

Q37132239-12158AD4-CFEF-47FD-A3D8-40FC0699841F

Q37132239-1446CBCF-5425-40D9-9491-7004D7E797BC

Q37132239-186EB55C-6FC7-43AD-8314-0EE0EF44DC06

Q37132239-22D169B7-AE76-4785-B32B-EFDC6AA4714C

Q37132239-295376A0-D6B8-49FF-A743-3A6C85FFAF59

Q37132239-32C341F5-A18B-4562-82D9-9A5F0D1C4CCD

Q37132239-33BE87FF-7C0E-42D5-AFCA-B86CE3F6033A

P304

Q37132239-E3056DEC-7745-4579-9826-64C04AE10F63

P31

Q37132239-E3B57513-10FB-4703-9CFC-EB589E70F72F

P356

Q37132239-BF2C78F7-E8B7-4C33-B6C7-4B669840FB1E

P407

Q37132239-F4789674-D3EF-46D2-BE6A-71BF50603378

P433

Q37132239-0BE3444D-11B4-4CB6-8E77-EBD99769118D

P478

Q37132239-06713B65-CF12-46A5-BDEF-4862536F1D8B

P50

Q37132239-E42C243B-1F24-475F-93DF-CAF6767DEA0E

Q37132239-E95C4056-FD29-4EA3-980B-C0AF90C9B1A3

P577

Q37132239-C24B3C74-9AA0-4D94-A793-BAD8D5F265F7

P5875

Q37132239-2FE97647-3DB8-450D-AE4A-B0E24D660E53

P698

Q37132239-BB8D56DE-5580-434A-9FB2-FA5FF96AD0A3

P921

Q37132239-7892076D-935D-4A85-A893-A449ABEC6F99

P932

Q37132239-02D9051D-9DDF-44C9-AD91-D2B083CE28C2

P356

P1433

P1476

Cerebral cortex and the clinic ...... : complexity and heterogeneity

@en

P2093

Alexandra K Zaleta

http://www.w3.org/2001/XMLSchema#string

David H Salat

http://www.w3.org/2001/XMLSchema#string

Doug Greve

http://www.w3.org/2001/XMLSchema#string

H Diana Rosas

http://www.w3.org/2001/XMLSchema#string

Nathanael Hevelone

http://www.w3.org/2001/XMLSchema#string

Stephanie Y Lee

http://www.w3.org/2001/XMLSchema#string

Vasanth Pappu

http://www.w3.org/2001/XMLSchema#string

P2860

A genomic screen in yeast implicates kynurenine 3-monooxygenase as a therapeutic target for Huntington disease.

Thresholding of statistical maps in functional neuroimaging using the false discovery rate

Early changes in Huntington's disease patient brains involve alterations in cytoskeletal and synaptic elements

Behind the scenes of functional brain imaging: a historical and physiological perspective

Neuronal activity in the primate supplementary, pre-supplementary and premotor cortex during externally and internally instructed sequential movements

Increase in kynurenic acid in Huntington's disease motor cortex

Whole brain segmentation: automated labeling of neuroanatomical structures in the human brain

The precuneus: a review of its functional anatomy and behavioural correlates

An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest

Effects of CAG repeat length, HTT protein length and protein context on cerebral metabolism measured using magnetic resonance spectroscopy in transgenic mouse models of Huntington's disease.

P304

1057-1068

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/BRAIN/AWN025

http://www.w3.org/2001/XMLSchema#string

P407

P433

Pt 4

http://www.w3.org/2001/XMLSchema#string

P478

131

http://www.w3.org/2001/XMLSchema#string

P50

Steven M Hersch

P577

2008-03-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5515597

http://www.w3.org/2001/XMLSchema#string

P698

18337273

http://www.w3.org/2001/XMLSchema#string

P921

Huntington disease

P932

2657201

http://www.w3.org/2001/XMLSchema#string